Surgical Morbidity and Mortality From the Multicenter Randomized Controlled NeoRes II Trial-Reference-Cited by-同舟云学术

Surgical Morbidity and Mortality From the Multicenter Randomized Controlled NeoRes II Trial

Published:2020-08-21 Issue:5 Volume:272 Page:684-689
ISSN:0003-4932
Container-title:Annals of Surgery
language:en
Short-container-title:

Author:

Nilsson Klara,Klevebro Fredrik,Rouvelas Ioannis,Lindblad Mats,Szabo Eva,Halldestam Ingvar,Smedh Ulrika,Wallner Bengt,Johansson Jan,Johnsen Gjermund,Aahlin Eirik Kjus,Johannessen Hans-Olaf,Hjortland Geir Olav,Bartella Isabel,Schröder Wolfgang,Bruns Christiane,Nilsson Magnus

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Surgery

Reference30 articles.

1. Esophageal and esophagogastric junction cancers, version 2.2019. NCCN Clinical Practice Guidelines in Oncology;Ajani;J Natl Compr Canc Netw,2019

2. Oesophageal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up;Stahl;Ann Oncol,2013

3. Preoperative irradiation for cancer of the esophagus;Cliffton;Cancer,1960

4. A randomized clinical trial of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the oesophagus or gastro-oesophageal junction;Klevebro;Ann Oncol,2016

5. Preoperative chemoradiotherapy for esophageal or junctional cancer;van Hagen;N Engl J Med,2012

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. United Kingdom and Ireland Oesophagogastric Cancer Group Cancer Update 2023;Clinical Oncology;2024-09

2. The Prognostic Impact of Minimally Invasive Esophagectomy on Survival After Esophagectomy Following a Delayed Interval After Chemoradiotherapy;Annals of Surgery;2024-06-21

3. Does the time interval from neoadjuvant camrelizumab combined with chemotherapy to surgery affect outcomes for locally advanced esophageal squamous cell carcinoma?;Journal of Cancer Research and Clinical Oncology;2024-03-27

4. Randomized controlled trial of nasogastric tube use after esophagectomy: study protocol for the kinetic trial;Diseases of the Esophagus;2024-02-16

5. Optimal Time-to-Surgery Recommendations Based on Primary Tumor Volume Regression for Patients with Resectable Esophageal Cancer after Neoadjuvant Chemoradiotherapy: A Retrospective Study;Annals of Surgical Oncology;2024-01-27